Mid-Day Market Update: Demandware Rises Following Acquisition News; Adeptus Health Shares Slide

Loading...
Loading...
Midway through trading Wednesday, the Dow traded down 0.31 percent to 17,732.83 while the NASDAQ declined 0.06 percent to 4,944.97. The S&P also fell, dropping 0.18 percent to 2,093.23.
Leading and Lagging Sectors
Wednesday morning, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. In trading on Wednesday, basic materials shares fell by 1.21 percent. Meanwhile, top losers in the sector included
Freeport-McMoRan IncFCX
, down 7 percent, and
Cliffs Natural Resources IncCLF
, down 6 percent.
Top Headline Michael Kors Holdings LtdKORS
reported better-than-expected Q4 earnings and issued a strong FY earnings forecast. The company announced a new $1 billion share buyback program. Michael Kors also revealed that it completed Michael Kors (HK) Limited acquisition, the exclusive licensee of the Company in China and some other jurisdictions in Asia. Michael Kors said it earned $0.98 per in the fourth quarter on revenue of $1.2 billion. Wall Street analysts were expecting the company to earn $0.97 per share on revenue of $1.2 billion. Michael Kors also provided guidance for its first quarter 2017 and expects total revenue to be in a range of $940 million to $950 million and earnings per share to be $4.47 to $4.55. Wall Street analysts were already estimating the company to see revenue of $1.03 billion in the quarter and earn $4.42 per share.
Equities Trading UP Demandware Inc DWRE
shares shot up 56 percent to $74.70 as
salesforce.com, inc. CRM
announced plans to buy Demandware in a $2.8 billion deal. Shares of
Ocean Power Technologies Inc
OPTT
got a boost, shooting up 296 percent to $5.79 following announcement of deal with Mitsui. The company has entered into a first commercial PB3 agreement with Mitsui Engineering and Shipbuilding worth $975,000.
Galena Biopharma IncGALE
Loading...
Loading...
shares were also up, gaining 20 percent to $2.17 as the company disclosed that the Food and Drug Administration has designated its NeuVax (nelipepimut-S), combined with recombinant granulocyte macrophage-colony stimulating factor (GM-CSF), as a Fast Track development program..
Equities Trading DOWN Ampliphi Biosciences CorpAPHB
shares dropped 27 percent to $2.27 as the company reported the pricing of its offering of 2,127,660 shares of common stock and warrants. Shares of
Daktronics, Inc.DAKT
were down 16 percent to $6.70 as the company reported downbeat Q4 results.
Adeptus Health IncADPT
was down, falling around 17 percent to $59.47 as the company issued a weak Q2 earnings forecast and reported a common stock offering of 2.75 million shares.
Commodities
In commodity news, oil traded down 1.65 percent to $48.29 while gold traded down 0.26 percent to $1,214.30. Silver traded up 0.19 percent Wednesday to $16.03, while copper fell 1.74 percent to $2.06.
Eurozone
European shares were lower today. The eurozone's STOXX 600 slipped 1.08 percent, the Spanish Ibex Index fell 1.44 percent, while Italy's FTSE MIB Index declined 1.28 percent. Meanwhile the German DAX dropped 0.72 percent, and the French CAC 40 declined 0.82 percent, while U.K. shares fell 0.78 percent.
Economics
The Markit manufacturing PMI rose to 50.70 in May, versus a prior reading of 50.50. However, economists were expecting a reading of 50.50. U.S. construction spending declined 1.80 percent for April, versus economists' expectations for a 0.60 percent growth. The ISM manufacturing index gained to 51.30 in May, versus a previous reading of 50.80. Economists were projecting a reading of 50.50.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceEurozoneCommoditiesM&AGlobalIntraday UpdateMarketsMoversMid-Day Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...